Open AccessThe cost-effectiveness and cost-utility analysis of the use of enoxaparin compared with heparin for venous thromboembolism prophylaxis in medical inpatients in Iran
Author(s) -
Mohammadreza Amirsadri,
Sarah Mousavi,
Ali Karimipour
Publication year - 2019
Publication title -
daru
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.645
H-Index - 42
eISSN - 2008-2231
pISSN - 1560-8115
DOI - 10.1007/s40199-019-00292-1
Subject(s) - medicine , cost effectiveness analysis , cost–utility analysis , cost effectiveness , psychological intervention , quality adjusted life year , cost–benefit analysis , venous thromboembolism , emergency medicine , surgery , thrombosis , risk analysis (engineering) , psychiatry , biology , ecology
Moderate to high risk medical inpatients are at increased risk of Venous Thromboembolism (VTE). The present study aims to investigate the cost-effectiveness and cost-utility of using Enoxaparin compared to Heparin in VTE prophylaxis in medical inpatients, from Iranian payer's perspective.